Generic placeholder image

Mini-Reviews in Medicinal Chemistry


ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Evaluation of the Pharmacological Descriptors Related to the Induction of Antidepressant Activity and its Prediction by QSAR/QRAR Methods

Author(s): S. Avram, C. Buiu, D. Duda-Seiman, C. Duda-Seiman, F. Borcan and D. Mihailescu

Volume 12, Issue 6, 2012

Page: [467 - 476] Pages: 10

DOI: 10.2174/138955712800493834

Price: $65


Antidepressants are psychiatric agents used for the treatment of different types of depression, being at present amongst the most commonly prescribed drugs, while their effectiveness and adverse effects are still the subject of many studies. To reduce the inefficiency of known antidepressants caused by their side-effects, many research efforts have recently focused on the development of improved strategies for new antidepressants drug design. For this reason it is necessary to apply very fast and precise techniques, such as QSAR (Quantitative Structure-Activity Relationships) and QRAR (Quantitative Retention-Activity Relationship), which are capable to analyze and predict the biological activity for these structures, taking in account the possible changes of the molecular structures and chromatographic parameters. We discuss the pharmaceutical descriptors (van der Waals, electrostatic, hydrophobicity, hydrogen donor/acceptor bond, Verloop's parameters, polar area) involved in QSAR and also chromatographic parameters involved in QRAR studies of antidepressants. Antidepressant activities of alkanol piperazine, acetamides, arylpiperazines, thienopyrimidinone derivatives (as preclinical antidepressants) and also the antidepressants already used in clinical practice are mentioned.

Keywords: Antidepressants, drug design, membrane receptors, QSAR, QRAR, pharmaceutical descriptors, histamine agonists, psychiatric drugs, melancholia, epinephrine, antidepressants, alignment-independent, thienopyrimidinone

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy